Wave life sciences to present at the chardan 7th annual genetic medicines conference

Cambridge, mass., sept. 25, 2023 (globe newswire) -- wave life sciences ltd. (nasdaq: wve), a clinical-stage rna medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced that paul bolno, md, mba, president and chief executive officer, is scheduled to present at the chardan 7th annual genetic medicines conference in new york city on monday, october 2, 2023. dr. bolno will participate in the adar editing panel at 9:30 a.m. et and an analyst-led fireside chat at 10:30 a.m. et.
WVE Ratings Summary
WVE Quant Ranking